Objectives

After participating in this educational activity, attendees should be able to:
1| Describe the rationale for pharmacist involvement in inhaler optimization and transitions of care for patient receiving chronic inhaler therapy.

2| Interpret the design and major clinical findings of the PILLAR randomized controlled trial.

3| Evaluate the strengths, limitations, and potential applicability of the PILLAR intervention to pharmacy practice.

Presenter(s): 
Reilly Stewart, PharmD
PGY1 Pharmacy Resident
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Reilly Stewart, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
10/26/2026 - 2:00pm to 3:00pm EDT
Location: 
Hybrid
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours
Please login or register to take this course.